Pinkerton Retirement Specialists’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.3M | Buy |
28,974
+125
| +0.4% | +$26.9K | 0.54% | 25 |
|
|
2026
Q1 | $6.59M | Sell |
28,849
-309
| -1% | -$68.5K | 0.6% | 28 |
|
|
2025
Q4 | $6.66M | Sell |
29,158
-228
| -0.8% | -$51.9K | 0.68% | 30 |
|
|
2025
Q3 | $6.8M | Buy |
29,386
+2,051
| +8% | +$418K | 0.73% | 28 |
|
|
2025
Q2 | $5.07M | Buy |
27,335
+1,055
| +4% | +$196K | 0.61% | 36 |
|
|
2025
Q1 | $5.51M | Buy |
26,280
+290
| +1% | +$56.4K | 0.71% | 20 |
|
|
2024
Q4 | $4.62M | Buy |
25,990
+1,086
| +4% | +$200K | 0.67% | 39 |
|
|
2024
Q3 | $4.92M | Buy |
24,904
+15
| +0.1% | +$2.8K | 0.72% | 37 |
|
|
2024
Q2 | $4.27M | Buy |
24,889
+1,957
| +9% | +$324K | 0.66% | 41 |
|
|
2024
Q1 | $4.18M | Buy |
22,932
+3,975
| +21% | +$685K | 0.67% | 32 |
|
|
2023
Q4 | $2.94M | Sell |
18,957
-1,021
| -5% | -$149K | 0.57% | 33 |
|
|
2023
Q3 | $2.98M | Buy |
19,978
+57
| +0.3% | +$8.37K | 0.65% | 28 |
|
|
2023
Q2 | $2.68M | Buy |
19,921
+532
| +3% | +$78K | 0.53% | 51 |
|
|
2023
Q1 | $3.09M | Buy |
19,389
+526
| +3% | +$80.4K | 0.58% | 36 |
|
|
2022
Q4 | $3.05M | Buy |
18,863
+998
| +6% | +$153K | 0.66% | 24 |
|
|
2022
Q3 | $2.4M | Sell |
17,865
-2,135
| -11% | -$306K | 0.92% | 28 |
|
|
2022
Q2 | $3.06M | Sell |
20,000
-3,710
| -16% | -$567K | 0.93% | 20 |
|
|
2022
Q1 | $3.84M | Buy |
23,710
+1,444
| +6% | +$210K | 0.86% | 22 |
|
|
2021
Q4 | $3.02M | Buy |
22,266
+543
| +2% | +$64.1K | 0.53% | 37 |
|
|
2021
Q3 | $2.34M | Buy |
21,723
+646
| +3% | +$73.8K | 0.45% | 63 |
|
|
2021
Q2 | $2.37M | Buy |
21,077
+468
| +2% | +$52.7K | 0.46% | 59 |
|
|
2021
Q1 | $2.23M | Buy |
20,609
+386
| +2% | +$41.3K | 0.47% | 59 |
|
|
2020
Q4 | $2.17M | Sell |
20,223
-1,364
| -6% | -$131K | 0.52% | 45 |
|
|
2020
Q3 | $1.89M | Sell |
21,587
-1,327
| -6% | -$125K | 0.52% | 57 |
|
|
2020
Q2 | $2.25M | Buy |
22,914
+7,541
| +49% | +$664K | 0.72% | 18 |
|
|
2020
Q1 | $1.17M | Buy |
+15,373
| New | +$1.31M | 0.82% | 31 |
|
|
2017
Q1 | – | Sell |
-259
| Closed | -$16K | – | 116 |
|
|
2016
Q4 | $16K | Sell |
259
-16
| -6% | -$977 | 0.01% | 346 |
|
|
2016
Q3 | $17K | Buy |
275
+85
| +45% | +$5.5K | 0.01% | 335 |
|
|
2016
Q2 | $12K | Buy |
190
+180
| +1,800% | +$11K | 0.01% | 369 |
|
|
2016
Q1 | $1K | Sell |
10
-112
| -92% | -$6.24K | ﹤0.01% | 210 |
|
|
2015
Q4 | $7K | Sell |
122
-33,852
| -100% | -$1.95M | ﹤0.01% | 91 |
|
|
2015
Q3 | $1.85M | Buy |
33,974
+162
| +0.5% | +$10.5K | 2.62% | 19 |
|
|
2015
Q2 | $2.27M | Buy |
33,812
+2,173
| +7% | +$142K | 1.41% | 18 |
|
|
2015
Q1 | $1.85M | Buy |
31,639
+1,235
| +4% | +$74.6K | 1.23% | 24 |
|
|
2014
Q4 | $1.99M | Buy |
+30,404
| New | +$1.92M | 1.52% | 16 |
|
Other funds holding ABBV
Pinkerton Retirement Specialists's ABBV Position: Q2 2026 in Review
Pinkerton Retirement Specialists increased its AbbVie (ABBV) stake by 0.43% in Q2 2026, buying an estimated $26.9K and bringing the position to 28,974 shares worth $6.3M. The position accounts for 0.54% of the portfolio, ranked #25.
Pinkerton Retirement Specialists first reported a position in ABBV in Q4 2014 and has held it in 35 quarters since. The position peaked at $6.8M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Pinkerton Retirement Specialists held 28,974 shares of AbbVie worth $6.3M as of Q2 2026.
- Pinkerton Retirement Specialists bought 125 AbbVie shares in Q2 2026, an estimated $26.9K.
- AbbVie made up 0.54% of Pinkerton Retirement Specialists's portfolio in Q2 2026, its #25 holding.
- Pinkerton Retirement Specialists first reported a position in AbbVie in Q4 2014 and has held it in 35 quarters since.
- Pinkerton Retirement Specialists's AbbVie position peaked at $6.8M in Q3 2025.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Pinkerton Retirement Specialists's 13F filing for Q2 2026, filed 30 Jul 2026.